Literature DB >> 9072789

[A comparative study of complications after vagotomy-pyloroplasty using Sugiura-Futagawa procedure and surgery of acid peptic disease].

H Orozco1, M A Mercado, J C Morales-Linares, T J Gómez-Méndez.   

Abstract

BACKGROUND: The frequency of complications of vagotomy and pyloroplasty for treating peptic disease is considerable. The modification of the Sugiura-Futagawa procedure includes bilateral truncal vagotomy and pyloroplasty as part of the devascularization, with a low frequency of related complications. AIM: To study the effects after VP in the outcome of both groups of patients.
RESULTS: The results of a retrospective, comparative, not randomized, controlled trial of 153 medical records of patients who underwent our modification of the Sugiura-Futagawa operation (SFO) due to Hemorrhagic Portal Hypertension (HPH), and 100 patients with bilateral truncal vagotomy and pyloroplasty (VP) due to Acid-Peptic Disease (APD) are presented. In both groups VP was done. The first group as part of SFO, and the second to treat their disease. We found 47 complications; 40 (40%) were observed in patients who underwent VP for APD and 7 (4%) in SFO: Post-vagotomy Diarrhea (PVD): 11% after APD and 2% after SFO. Dumping Syndrome (DS): 22% and 1%, and Alkaline Reflux Gastritis (ARG): 7% and 0.5% respectively. The calculated risk of developing complications related to vagotomy and pyloroplasty in peptic ulcer disease was 14 times higher.
CONCLUSIONS: The incidence of these post VP complications at the SFO group was low (4%), in relation to 40% for the APD; the outcomes were statistically significative (p < 0.05).

Entities:  

Mesh:

Year:  1996        PMID: 9072789

Source DB:  PubMed          Journal:  Rev Gastroenterol Mex        ISSN: 0375-0906


  1 in total

1.  New operative method for fundal variceal bleeding: fundectomy with periesophagogastric devascularization.

Authors:  Ho-Seong Han; Nam-Joon Yi; Young-Woo Kim; Gary D Fleischer
Journal:  World J Surg       Date:  2004-03-04       Impact factor: 3.352

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.